{"id":"W2411638242","doi":"10.1007/s11060-016-2155-4","title":"Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study","year":2016,"lang":"en","type":"article","venue":"Journal of Neuro-Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hospital for Sick Children","funders":"Astellas Pharma Global Development","keywords":"Medicine; Erlotinib; Etoposide; Internal medicine; Randomized controlled trial; Oncology; Surgery; Gastroenterology; Chemotherapy; Epidermal growth factor receptor; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001877519,0.0002705207,0.001686739,0.0005172543,0.00007470966,0.00002974134,0.0004292711,0.00009560215,0.0001063955],"category_scores_gemma":[0.005295177,0.0001289184,0.0001034329,0.000417649,0.0001816086,0.0003058588,0.0003720569,0.0007133498,0.00001647829],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001515382,"about_ca_system_score_gemma":0.001408155,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002789643,"about_ca_topic_score_gemma":0.0002565926,"domain_scores_codex":[0.9956442,0.001420519,0.001144651,0.0003552839,0.0009312941,0.0005040981],"domain_scores_gemma":[0.9943889,0.003302469,0.0009923611,0.0002972709,0.000695699,0.0003232835],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8812462,0.01733994,0.06201211,0.0000466485,0.0005419256,0.005189325,0.0008938416,8.053011e-7,0.0004559994,0.000003515895,0.004783235,0.02748642],"study_design_scores_gemma":[0.8368716,0.1060773,0.04803826,0.0001437607,0.0007334659,0.0001847596,0.0002985732,0.00000267842,0.00004217542,0.00001170572,0.007419984,0.0001757283],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914091,0.000346917,0.00001277364,0.003275965,0.001603275,0.002864596,0.000006377983,0.00001276227,0.0004682073],"genre_scores_gemma":[0.9977298,0.0005667488,0.0007669257,0.0002766341,0.000360894,0.0000949168,0.000001077344,0.00004394979,0.0001590199],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08873735,"threshold_uncertainty_score":0.6339204,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1056974383727223,"score_gpt":0.4132313048433015,"score_spread":0.3075338664705791,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}